The ACMG Foundation’s Corporate Partners Program makes our key initiatives possible. Corporate gifts support many of our annual programs by generously supplementing individual donations and other targeted grants. ACMG’s clinical and laboratory practice guidelines, advocacy campaigns, continuing education programs, and the Foundation’s work to steer medical students into the genetics and genomics field – these all depend on corporate support.

Our Corporate partners offer much more than financial support. As representatives of some of the most prestigious genetics and genomics companies in the world, CPP member companies are dedicated to making an impact by exchanging information. Several CPP member companies lend their staff expertise and mentor our next generation leaders. We engage them in shaping ideas, improving legislation, strengthening networks, and providing resources to ACMG’s emerging professionals.

The benefits are mutual, as our corporate donors also engage with ACMG members. Our global community of board-certified geneticists covers all practice areas of genetic and genomic medicine. ACMG members recognize that therapeutic, diagnostic, and associated businesses are our natural allies in translating genes into health. ACMG and the ACMG Foundation provide a forum where industry, academics, and invested individuals come together to improve the diagnosis and treatment of genetic diseases.

"Think of giving not only as a duty but as a privilege." - John Rockefeller

The ACMG Foundation’s Corporate Partners Program makes our key initiatives possible.
Thank you to our Corporate Partners for their generous support!

Platinum Partners

 

Pfizer logo

Gold Partners

Sparks Therapeutics logo

Perkin Elmer logo

Silver Partners

PTC logo

Myriad logo

Johnson & Johnson logo

Illumina logo

Alexion logo

Friend Partners

BioMarin logo

Bio-Rad logo

Ultragenyx logo

myome logo

23andMe logo

The ACMG Foundation also thanks the following companies for their cumulative gifts:

More than $400,000: Bionano
More than $500,000: BioMarin
More than $1 million: Revvity,  Pfizer, Inc.
More than $1.5 million: Illumina, Inc.,  Takeda
More than $2 million: Sanofi